SciSparc

SciSparc

Pharmaceuticals
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company’s operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

$2.3M

Market Cap • 10/13/2026

2004

(22 years)

Founded

2021

(5 years ago)

IPO

NASDAQ

Listing Exchange

Flag of Israel

Israel

Country

Valuation

P/B

0,6

P/S

3,4

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

0,1

BVPS

6,8

EPS

—

Market Cap

Market Cap

2,3M

EV

7,9M

EV/Revenue

11,6

EV/EBITDA

-1,8

EV/EBIT

-1,7

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-217,6%

Total Yield

-217,6%

Payout

0%

Retained Earnings

-92,5M

Profitability

Gross Margin

71,1%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

402,7%

Capex/Revenue

0%

Capex/D&A

0%

Capex/OCF

0%

SBC/OCF

—

% PPE

0,1%

% Goodwill

0%

ROE

—

ROIC

—

Growth

CAGR Op. Income 5Y

4,4%

CAGR Net Income 5Y

35%

CAGR OCF 5Y

2,6%

Leverage

N.D./EBITDA

0,4

Debt/Equity

0%

Current Ratio

0,9

Quick Ratio

0,9

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium